Thomas A. Shea
Director of Finance/CFO at ImmunoMolecular Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Gottlieb | M | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | 9 years |
| Aaron Michels | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | 9 years |
| Jonathan Rigby | M | 56 |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | 3 years |
| Stephen Dilly | M | 64 |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | 4 years |
| Nandan Padukone | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | - |
| Ed Orr | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy E. Smith | M | - |
Babson College
| 11 years |
| Andrea Corcoran | F | 61 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | 4 years |
| Johannes F. Weber | M | - |
Babson College
| 5 years |
| William Francis Coughlin | M | - |
Babson College
| 6 years |
| Jonathan Rothbard | M | 72 |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 6 years |
| Ralph Z. Sorenson | M | 90 |
Babson College
| 7 years |
| Peter McNally | M | - |
Babson College
| 4 years |
| Richard F. Fernandez | M | 81 |
Babson College
| 2 years |
| Stuart Benton | M | 59 |
Suffolk University
| 2 years |
| Daniel Joseph Moore | M | 63 |
Babson College
| 4 years |
| Chuck Garabedian | M | - |
Suffolk University
| 2 years |
| Stacey M. Page | F | 60 |
Babson College
| 4 years |
| Paul Charow is Chief Charow | M | - |
Babson College
| 2 years |
| Michael H. Gurau | M | - |
Babson College
| 4 years |
| Antonin Rollet de Fougerolles | M | 59 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | 1 years |
| Nancy F. Smith | F | - |
Babson College
| 2 years |
| Leo M. O'Brien | M | - |
Babson College
| 2 years |
| Roger Roche | M | - |
Babson College
| 5 years |
| Bill Allard | M | - |
Babson College
| 4 years |
| Gary Merrill | M | - |
Babson College
| 2 years |
| Brian D. Lanigan | M | - |
Babson College
| 2 years |
| Brian Caffyn | M | 63 |
Babson College
| 4 years |
| Daniel M. Schwartz | M | - |
Babson College
| 4 years |
| Randy W. Hollstein | M | 67 |
Babson College
| 4 years |
| Rob Galusza | M | - |
Babson College
| 4 years |
| Trip Millikin | M | - |
Babson College
| 4 years |
| Jay Turley | M | - |
Babson College
| 4 years |
| Thomas Teebagy | M | 65 |
Babson College
| 2 years |
| Aoife Brennan | M | 48 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | 3 years |
| Terrence Arthur Beaton | M | - |
Babson College
| 4 years |
| Paul Francis Duval | M | - |
Babson College
| 5 years |
| Yoong Yoon Liong | M | 73 |
Babson College
| 2 years |
| Paul Berman | M | - |
Babson College
| 3 years |
| Sandra Eve | F | - |
Babson College
| 4 years |
| Randy Scherago | M | - |
Babson College
| 4 years |
| Scott B. Seidman | M | 64 |
Babson College
| 4 years |
| Mark E. Dunn | M | - |
Babson College
| 4 years |
| David MacDonald | M | - |
Babson College
| 4 years |
| Roberto Feliciano | M | 70 |
Babson College
| 2 years |
| James Sia | M | - |
Babson College
| 4 years |
| Stephen Popper | M | - |
Babson College
| 4 years |
| Peter R. Fleming | M | - |
Suffolk University
| 2 years |
| Kevin Smith | M | - |
Babson College
| 2 years |
| Mark Ahnrud | M | - |
Babson College
| 4 years |
| Donna M. Jarlenski | F | - |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | 2 years |
| Titus M. F. M. Plattel | M | - |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | 3 years |
| Scott G. Campbell | M | - |
Babson College
| 4 years |
| James F. McCann | M | - |
Babson College
| 4 years |
| William J. Allard | M | - |
Babson College
| 4 years |
| Michael A. DeBernardi | M | 70 |
Babson College
| 2 years |
| A. Levison | M | 67 |
Babson College
| - |
| Bob Zenouzi | M | - |
Babson College
| 4 years |
| Daniel J. Mainolfi | M | - |
Babson College
| 4 years |
| Kevin P. Lawler | M | - |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 8 years |
| Rich Erwin | M | - |
Babson College
| 2 years |
| Dennis H. Bunt | M | 70 |
Babson College
| 2 years |
| Sean Moran | M | 66 |
Babson College
| 4 years |
| Christopher Ray Ely | M | - |
Babson College
| 5 years |
| Malcolm Morville | M | 78 |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 5 years |
| Paul J. Cunningham | M | 61 |
Babson College
| 4 years |
| Dan Omstead | M | 71 |
Ebi Life Sciences, Inc.
 Ebi Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ebi Life Sciences, Inc. is a private company that specializes in researching and developing life sciences. The company is based in Cambridge, MA. | 2 years |
| Stefan Ryser | M | 64 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | - |
| Paul D. Baker | M | 66 |
Babson College
| 4 years |
| Michael J. Soja | M | 74 |
Babson College
| 2 years |
| W. Heavey | M | - |
Babson College
| 4 years |
| Edmund Mahoney | M | 73 |
Babson College
| 3 years |
| Neal H. Goldman | M | 71 |
Babson College
| 2 years |
| Richard Bagley | M | 80 |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | 4 years |
| William H. Ahern | M | 64 |
Babson College
| 4 years |
| Gobind Sahney | M | 62 |
Babson College
| 4 years |
| Walter Zagrobski | M | - |
Babson College
| 4 years |
| David H. M. Baker | M | - |
Babson College
| 4 years |
| Albert J. Mercuri | M | 67 |
Babson College
| 4 years |
| Barry A. Schub | M | - |
Babson College
| 2 years |
| Steven I. Feinstein | M | - |
Babson College
| 4 years |
| Evan Jeffery Haberman | M | - |
Babson College
| 3 years |
| Steve Cacciatore | M | - |
Babson College
| 5 years |
| Jamie Austin | M | - |
Babson College
| 4 years |
| David W. Sargent | M | - |
Babson College
| 4 years |
| Kenneth G. Romanzi | M | 64 |
Babson College
| 4 years |
| Michael F. Dale | M | - |
Babson College
| 4 years |
| Brady Bohrmann | M | - |
Babson College
| 4 years |
| Jeffrey Zimmer | M | 66 |
Babson College
| 2 years |
| Richard Teel | M | - |
Babson College
| 4 years |
| Eileen McCarthy Toti | F | - |
Babson College
| 2 years |
| David J. Duval | M | - |
Babson College
| 2 years |
| Martha D. Vorlicek | F | - |
Babson College
| 4 years |
| Rick Renwick | M | 67 |
Babson College
| 4 years |
| Bill Robert Fearnley | M | - |
Babson College
| 4 years |
| Jurrien Timmer | M | - |
Babson College
| 4 years |
| Thomas Lydon | M | 64 |
Babson College
| 4 years |
| Akio Toyoda | M | 68 |
Babson College
| 2 years |
| Peter S. Kaplan | M | - |
Babson College
| 2 years |
| Angela Ciampa | F | - |
Suffolk University
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas A. Shea
- Personal Network
